As cell therapies move into broader disease areas, developers face increasing pressure to demonstrate manufacturing readiness. John Tomtishen discusses why CMC considerations are shifting from a ...

Infinitopes has dosed the first patient with ITOP1, its lead investigational therapeutic cancer vaccine, marking the first ...

Falling token prices haven't lowered enterprise AI bills. As organizations expand agentic AI and process more data, hidden ...

The recurrent attacks renew questions about the country’s energy security, export dependence and the growing challenge of preserving its balanced foreign policy. The tankers Asia and Nissos Ios were ...

A splash. A shout. And then — chaos. A man overboard situation is one of the most terrifying emergencies that can unfold at ...

TrapLink, a solar-powered monitoring system developed in Oklahoma, uses artificial intelligence to identify New World ...

In a village agricultural livestream studio in Tonglu, Klara Tania Tandika, an Indonesian YouTuber with over 23 million ...

This is the eighth in an ongoing series of features highlighting authors and new books published by Torrey House Press in ...

Safety will be the key determinant of in vivo CAR T therapies, according to H.C. Wainwright’s Mitchel Kapoor, who noted that convenience and efficacy won’t be enough to impress investors in this space ...

Morgan Stanley raises Cognizant (CTSH) price target to $51, citing a differentiated AI strategy, bookings trends, and ...